Crux Biolabs
Bayswater
About Crux Biolabs
Crux provides specialised immunology contract research services for pre-clinical and clinical studies, as well as academic and biotech R&D.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Private Equity
- Last round: Private Equity (Aug 2022)
- Website: cruxbiolabs.com
- Phone: +61 3 9763 0110
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/crux-biolabs-2428258 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.